Filing Details
- Accession Number:
- 0001237899-14-000021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-19 16:10:29
- Reporting Period:
- 2014-02-14
- Filing Date:
- 2014-02-19
- Accepted Time:
- 2014-02-19 16:10:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1391382 | J Robert Terifay | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Commercial | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-02-14 | 27,795 | $21.25 | 47,824 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-02-14 | 1,826 | $323.30 | 45,998 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-14 | 13,104 | $323.30 | 32,894 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2014-02-18 | 3,497 | $331.66 | 29,397 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-18 | 6,603 | $332.75 | 22,794 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-02-18 | 2,765 | $333.79 | 20,029 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-14 | 27,795 | $0.00 | 27,795 | $21.25 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 48,750 | 2019-12-18 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 1,620 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 3,497 shares of Company stock on February 18, 2014 at prices ranging from $331.33 to $332.33. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
- Represents volume-weighted average price of sales of 6,603 shares of Company stock on February 18, 2014 at prices ranging from $332.34 to $333.29. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
- Represents volume-weighted average price of sales of 2,765 shares of Company stock on February 18, 2014 at prices ranging from $333.45 to $334.34. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 18, 2014 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
